Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma
- 1 January 2005
- journal article
- research article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 71 (2) , 173-180
Abstract
Background: Magnetic resonance spectroscopy imaging (MRSI) non-invasively evaluates the metabolic profile of normal and abnormal brain tissue. Primary central nervous system lymphoma (PCNSL) is a highly aggressive tumor responsive to high-dose methotrexate based regimens. Patients often have complete responses but relapses are common. We characterized the MR spectra of PCNSL patients, correlated MRSI with MRI and evaluated whether early recurrence could be detected by MRSI. Methods: Patients with PCNSL had multi-voxel MRSI before, during, and after treatment. The region of interest was defined using axial FLAIR images. Metabolites assessed were N-acetyl-aspartate (NAA), choline (Cho), creatine (Cr), lipid, and lactate. Ratios of Cho/Cr, NAA/Cho, and NAA/Cr were calculated and correlated with MRI. Overall survival (OS), progression free survival (PFS), and relative risks of each of the ratios were determined. Results: MRSI was performed on 11 men and seven women; median age of 59. Sixty-seven MRSI studies were performed, 17 baseline and 48 follow-up studies. Median ratios in 16 pretreated patients were Cho/Cr-1.90, NAA/Cho-0.39, and NAA/Cr-1.27. Two patients had lipid at baseline, five had lactate and two had both. MRSI correlated with tumor response or progression on MRI; in three patients MRSI suggested disease progression prior to changes on MRI. Univariate analysis of metabolite ratios, lipid, and lactate revealed that none significantly affected PFS or OS. Kaplan–Meier analysis of the presence or absence of lipid, lactate or both revealed a trend for increased PFS. Conclusion: MRSI and MRI correlate with tumor response or progression and may allow early detection of disease recurrence. The presence or absence of lipid and/or lactate may have prognostic significance. Further research using MRSI needs to be done to validate our findings and determine the role of MRSI in PCNSL.Keywords
This publication has 42 references indexed in Scilit:
- Characterization of oligodendrogliomas using short echo time 1H MR spectroscopic imagingNMR in Biomedicine, 2003
- Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopyMagnetic Resonance in Medicine, 2003
- Correlations between Magnetic Resonance Spectroscopy and Image-guided Histopathology, with Special Attention to Radiation NecrosisNeurosurgery, 2002
- Increased choline levels coincide with enhanced proliferative activity of human neuroepithelial brain tumorsNMR in Biomedicine, 2002
- Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapyJournal of Neurosurgery, 1997
- Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter studyJournal of Neurosurgery, 1996
- Localized proton spectroscopy of inoperable brain gliomas. Response to radiation therapyJournal of Neuro-Oncology, 1993
- Development of the “activated” high resolution 1H MR spectrum in murine T cells and B cells occurs in G1 phase of the cell cycleMagnetic Resonance in Medicine, 1990
- Proton Nuclear Magnetic Resonance of Intact Friend Leukemia Cells: Phosphorylcholine Increase During DifferentiationScience, 1982
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958